https://rheumnow.live/p/s/insights-into-preclinical-rheumatoid-arthritis-17
https://rheumnow.live/p/s/the-development-and-clinical-application-of-jak-inhibition-26
https://rheumnow.live/p/s/methotrexate-who-would-have-predicted-its-impact-in-ra-29
https://rheumnow.live/p/s/the-history-of-steroids-39
https://rheumnow.live/p/s/the-history-of-measuring-targets-in-arthritis-45
https://rheumnow.live/p/s/the-history-of-fibromyalgia-53
https://rheumnow.live/p/s/the-anti-rheumatic-drug-use-during-pregnancy-61
https://rheumnow.live/p/s/immune-related-adverse-events-with-checkpoint-inhibitors-68
https://rheumnow.live/p/s/infection-prevention-and-management-with-newer-agents-76
https://rheumnow.live/p/s/the-science-of-piano-playing-and-the-art-of-medicine-82
https://rheumnow.live/p/s/inflammation-going-wrong-89
https://rheumnow.live/p/s/the-untold-story-behind-bone-marrow-edema-91
https://rheumnow.live/p/s/new-data-and-evolving-trends-in-psoriatic-arthritis-therapy-93
https://rheumnow.live/p/s/distinguishing-psoriatic-and-osteoarthritis-95
https://rheumnow.live/p/s/psoriasis-update-for-rheumatologists-97
https://rheumnow.live/p/s/new-criteria-guidelines-and-outcomes-in-lupus-100
https://rheumnow.live/p/s/lupus-therapeutics-novel-strategies-to-improve-outcomes-106
https://rheumnow.live/p/s/antiphospholipid-syndromes-catastrophic-or-not-107
https://rheumnow.live/p/s/the-art-and-science-of-empathy-in-rheumatology-112
https://rheumnow.live/p/s/the-coach-115
https://rheumnow.live/p/s/the-diagnosis-of-shoulder-pathology-122
https://rheumnow.live/p/s/joint-replacement-where-weve-been-where-were-going-123
https://rheumnow.live/p/s/dx-management-and-monitoring-of-granulomatosis-with-polyangiitis-127
https://rheumnow.live/p/s/mimics-of-vasculitis-130
https://rheumnow.live/p/s/advances-in-diagnosis-and-treatment-of-giant-cell-arteritis-131
https://rheumnow.live/p/s/the-good-the-bad-and-the-ugly-of-peer-review-and-scientific-publishing-137
https://rheumnow.live/p/s/how-randomized-clinical-trials-fail-us-146
https://rheumnow.live/p/s/epidemiology-and-genetics-of-spondyloarthritis-147
https://rheumnow.live/p/s/whats-the-deal-with-non-radiographic-axial-spondyloarthritis-153
https://rheumnow.live/p/s/the-changing-paradigm-in-spondylitis-155
https://rheumnow.live/p/s/rheumnow-live-recap-164
https://rheumnow.live/p/cf/rheumnow-pre-conference-lectures-176
https://rheumnow.live/p/s/dr-cush-introduction-to-infection-prevention-and-management-with-newer-agents-184
https://rheumnow.live/p/s/dr-kavanaugh-new-data-evolving-trends-in-psoriatic-arthritis-therapy-194
https://rheumnow.live/p/s/panel-q-and-a-orthopedic-faculty-207
https://rheumnow.live/p/s/pod-1-rheumatoid-arthritis-view-entire-session-and-q-and-a-panel-227
https://rheumnow.live/p/s/dr-holers-insights-into-preclinical-rheumatoid-arthritis-238
https://rheumnow.live/p/s/dr-weinblatt-methotrexate-who-would-have-predicted-its-impact-in-ra-245
https://rheumnow.live/p/s/step-session-the-history-of-rheumatology-view-all-ted-like-talks-254
https://rheumnow.live/p/s/pod-2-new-safety-data-view-entire-sesssion-and-q-and-a-panel-261
https://rheumnow.live/p/s/step-session-masters-of-the-eu-view-all-ted-like-talks-268
https://rheumnow.live/p/s/pod-3-advancing-the-science-of-psoriatic-disease-view-entire-sesssion-and-q-and-a-panel-275
https://rheumnow.live/p/s/pod-4-the-lupus-mavens-view-entire-sesssion-and-q-and-a-panel-284
https://rheumnow.live/p/s/step-session-featuring-the-rheumnow-live-faculty-view-all-ted-like-talks-295
https://rheumnow.live/p/s/pod-5-orthopedics-for-rheums-view-entire-sesssion-and-q-and-a-panel-303
https://rheumnow.live/p/s/pod-6-progress-in-vasculitis-view-entire-sesssion-and-q-and-a-panel-310
https://rheumnow.live/p/s/step-session-the-debunkers-view-all-ted-like-talks-320
https://rheumnow.live/p/s/pod-7-spondylitis-master-class-view-entire-sesssion-and-q-and-a-panel-327
https://rheumnow.live/p/s/dr-cush-pre-learning-lecture-335
https://rheumnow.live/p/s/panel-q-and-a-rheumatoid-arthritis-faculty-347
https://rheumnow.live/p/s/panel-q-and-a-safety-faculty-356
https://rheumnow.live/p/s/panel-q-and-a-psoriatic-faculty-364
https://rheumnow.live/p/s/benchmark-lecture-drug-costs-in-america-the-bad-the-worse-and-the-despicable-370
https://rheumnow.live/p/s/panel-q-and-a-lupus-faculty-381
https://rheumnow.live/p/s/panel-q-and-a-vasculitis-faculty-387
https://rheumnow.live/p/s/panel-q-and-a-spondylitis-faculty-395
https://rheumnow.live/p/s/dr-monach-advances-in-diagnosis-and-treatment-of-gca-404
https://rheumnow.live/p/s/dr-calabrese-immune-related-adverse-events-with-checkpoint-inhibitors-413
https://rheumnow.live/p/s/dr-ruderman-whats-the-deal-with-non-radiographic-spa-423
https://rheumnow.live/lessons/11/index
https://rheumnow.live/lessons/11/index
https://rheumnow.live/lessons/11/index
https://rheumnow.live/lessons/11/index
https://rheumnow.live/lessons/11/index
https://rheumnow.live/p/s/dr-conaghan-distinguishing-psa-and-osteoarthritis-487
https://rheumnow.live/p/s/1-dr-furie-lupus-therapeutics-novel-strategies-to-improve-outcomes-520
https://rheumnow.live/p/s/dr-oshea-the-development-and-clinical-application-of-jak-inhibition-530
https://rheumnow.live/lessons/11/index
https://rheumnow.live/p/s/welcome-and-game-plan-555
https://rheumnow.live/p/s/program-kick-off-561
https://rheumnow.live/p/s/dr-erkan-antiphospholipid-syndrome-catastrophic-or-not-571
https://rheumnow.live/p/s/dr-sammaritano-anti-rheumatic-drug-use-during-pregnancy-591
https://rheumnow.live/lessons/11/index
https://rheumnow.live/p/s/dr-husni-the-changing-paradigm-in-spondyloarthritis-607
https://rheumnow.live/p/s/rheumnow-live-preview-drs-cush-and-kavanaugh-628
https://rheumnow.live/p/s/dr-seo-introduction-to-mimics-of-vasculitis-638
https://rheumnow.live/lessons/11/index
https://rheumnow.live/p/s/dr-reveille-introduction-to-epidemiology-and-genetics-of-spondyloarthritis-661
https://rheumnow.live/lessons/11/index
https://rheumnow.live/p/s/dr-mathis-introduction-to-joint-replacement-where-weve-been-and-where-we-are-going-681
https://rheumnow.live/p/s/ce-pre-test-777
https://rheumnow.live/p/s/post-test-please-complete-post-event-856
https://rheumnow.live/p/s/pre-test-864
https://rheumnow.live/p/s/pre-test-on-demand-1344
https://rheumnow.live/p/s/welcome-and-game-plan-1381
https://rheumnow.live/p/s/pod-1-rheumatoid-arthritis-i-1387
https://rheumnow.live/p/s/management-of-infections-tb-and-zoster-in-rheum-1393
https://rheumnow.live/p/s/advances-in-ra-therapy-for-2020-1401
https://rheumnow.live/p/s/cardiovascular-risk-management-in-ra-1406
https://rheumnow.live/p/s/panel-q-and-a-rheumatoid-arthritis-faculty-1413
https://rheumnow.live/p/s/step-session-the-history-of-rheumatology-1423
https://rheumnow.live/p/s/the-history-of-lupus-1431
https://rheumnow.live/p/s/seeing-is-believing-medical-imaging-in-rheumatology-1438
https://rheumnow.live/p/s/the-history-of-hla-b27-1441
https://rheumnow.live/p/s/pod-2-advancing-the-management-of-psoriatic-arthritis-1458
https://rheumnow.live/p/s/psa-strategic-approaches-and-therapeutic-options-1463
https://rheumnow.live/p/s/psoriasis-for-the-rheumatologist-1468
https://rheumnow.live/p/s/the-curse-of-comorbidities-in-psoriasis-and-psa-1477
https://rheumnow.live/p/s/panel-q-and-a-1483
https://rheumnow.live/p/s/keynote-address-beliefs-reality-and-consequences-1518
https://rheumnow.live/p/s/step-session-international-masterminds-1528
https://rheumnow.live/p/s/the-future-of-rheumatology-1538
https://rheumnow.live/p/s/early-arthritis-are-we-doing-this-right-1544
https://rheumnow.live/p/s/pod-3-rheumatoid-arthritis-ii-1571
https://rheumnow.live/p/s/seronegative-vs-seropositive-ra-1578
https://rheumnow.live/p/s/methotrexate-mechanisms-1584
https://rheumnow.live/p/s/update-on-imaging-in-ra-1593
https://rheumnow.live/p/s/panel-q-and-a-1603
https://rheumnow.live/p/s/pod4-lupus-and-autoimmune-disease-1618
https://rheumnow.live/p/s/planning-and-managing-lupus-pregnancy-1626
https://rheumnow.live/p/s/difficult-lupus-putting-the-wolf-back-in-its-lair-1633
https://rheumnow.live/p/s/lupus-skin-disease-and-mimics-1643
https://rheumnow.live/p/s/panel-q-and-a-1647
https://rheumnow.live/p/s/step-session-future-of-rheumatology-practice-1653
https://rheumnow.live/p/s/telerheumatology-1662
https://rheumnow.live/p/s/manpower-shifts-in-rheumatology-1669
https://rheumnow.live/p/s/delivering-patient-centered-care-in-an-it-laden-world-1679
https://rheumnow.live/p/s/pod-5-living-with-a-chronic-disease-a-patients-perspective-1697
https://rheumnow.live/p/s/a-psa-patient-view-1703
https://rheumnow.live/p/s/living-with-a-chronic-disease-a-patients-perspective-1709
https://rheumnow.live/p/s/panel-q-and-a-1716
https://rheumnow.live/p/s/pod-6-autoinflammatory-disorders-1736
https://rheumnow.live/p/s/the-inflammasome-and-inate-immunity-1742
https://rheumnow.live/p/s/evaluation-and-testing-in-febrile-disorders-1748
https://rheumnow.live/p/s/aosd-pearls-on-dx-and-rx-1757
https://rheumnow.live/p/s/panel-q-and-a-1766
https://rheumnow.live/p/s/step-session-young-turk-podcasters-1772
https://rheumnow.live/p/s/using-questions-to-enhance-rheumatology-education-1781
https://rheumnow.live/p/s/evidence-based-rheumatology-to-improve-your-practice-1782
https://rheumnow.live/p/s/pod-7-spondylitis-master-class-1798
https://rheumnow.live/p/s/advances-in-spondyloarthritis-1807
https://rheumnow.live/p/s/the-gut-joint-axis-ibd-arthritis-1814
https://rheumnow.live/p/s/imaging-of-as-and-spa-1823
https://rheumnow.live/p/s/panel-q-and-a-1833
https://rheumnow.live/p/s/rheumnow-live-roundup-1848
https://rheumnow.live/p/s/break-in-the-exhibit-hall-1856
https://rheumnow.live/p/s/panel-q-and-a-autoinflammatory-faculty-1964
https://rheumnow.live/p/s/lupus-skin-disease-and-mimics-2104
https://rheumnow.live/p/s/the-history-of-hla-b27-2298
https://rheumnow.live/p/s/break-in-the-exhibit-hall-2304
https://rheumnow.live/lessons/19/index
https://rheumnow.live/lessons/19/index
https://rheumnow.live/lessons/19/index
https://rheumnow.live/lessons/19/index
https://rheumnow.live/p/s/newman-2486
https://rheumnow.live/p/s/kavanaugh-intro-2494
https://rheumnow.live/p/s/kav-video-2-2503
https://rheumnow.live/lessons/19/index
https://rheumnow.live/p/s/4-2020-cush-prelearn-video-2643
https://rheumnow.live/lessons/19/index
https://rheumnow.live/lessons/19/index
https://rheumnow.live/lessons/19/index
https://rheumnow.live/p/s/2020-atul-2677
https://rheumnow.live/lessons/19/index
https://rheumnow.live/lessons/19/index
https://rheumnow.live/lessons/19/index
https://rheumnow.live/p/s/rheumnow-live-2020-pre-test-2732
https://rheumnow.live/p/s/rheumnow-live-2020-evaluation-2739
https://rheumnow.live/p/cf/rheumnow-live-2021-2811
https://rheumnow.live/p/s/welcome-remarks-and-pod-1-rheumatoid-arthritis-i-2818
https://rheumnow.live/p/s/future-therapies-in-ra-2828
https://rheumnow.live/p/s/difficult-ra-2833
https://rheumnow.live/p/s/ra-treatment-paradigms-eular-2019-and-acr-2020-guidelines-2838
https://rheumnow.live/p/s/ra-faculty-panel-discussion-and-audience-q-and-a-2843
https://rheumnow.live/p/s/step-session-international-faculty-2848
https://rheumnow.live/p/s/new-lessons-from-older-drugs-in-rheumatology-2853
https://rheumnow.live/p/s/glucocorticoids-in-ra-past-present-and-future-2858
https://rheumnow.live/p/s/pod-2-lupus-challenges-2868
https://rheumnow.live/p/s/thrombotic-risks-in-lupus-2873
https://rheumnow.live/p/s/ethnic-disparities-in-sle-2878
https://rheumnow.live/p/s/dermatopathology-in-lupus-2883
https://rheumnow.live/p/s/lupus-faculty-panel-discussion-and-audience-q-and-a-2888
https://rheumnow.live/p/s/pod-3-psoriatic-disease-management-2898
https://rheumnow.live/p/s/advancing-treatment-in-psoriatic-arthritis-2903
https://rheumnow.live/p/s/psoriatic-disease-its-health-impact-and-what-we-may-be-missing-2908
https://rheumnow.live/p/s/epidemiology-of-psoriasis-and-psa-2913
https://rheumnow.live/p/s/psoriatic-faculty-panel-discussion-and-audience-q-and-a-2918
https://rheumnow.live/p/s/step-session-covid-and-rheumatology-practice-2923
https://rheumnow.live/p/s/education-and-training-during-covid-2928
https://rheumnow.live/p/s/update-global-rheumatology-alliance-registry-2933
https://rheumnow.live/p/s/pod-4-rheumatoid-arthritis-ii-2943
https://rheumnow.live/p/s/pneumonia-and-rheumatoid-arthritis-2948
https://rheumnow.live/p/s/interstitial-lung-disease-in-ra-2953
https://rheumnow.live/p/s/ild-faculty-panel-discussion-and-audience-q-and-a-2958
https://rheumnow.live/p/s/keynote-address-best-of-times-worst-of-times-2963
https://rheumnow.live/p/s/pod-5-spondyloarthritis-advances-2968
https://rheumnow.live/p/s/treatment-advances-in-spondyloarthritis-2973
https://rheumnow.live/p/s/enthesitis-and-dactylitis-management-2978
https://rheumnow.live/p/s/iritis-and-hla-b27-2983
https://rheumnow.live/p/s/spondyloarthritis-faculty-panel-discussion-and-audience-q-and-a-2988
https://rheumnow.live/p/s/pod-6-rheumatoid-arthritis-iii-2998
https://rheumnow.live/p/s/managing-ra-and-the-liver-3003
https://rheumnow.live/p/s/epigenetics-in-ra-3008
https://rheumnow.live/p/s/acr-covid-vaccine-guidance-3013
https://rheumnow.live/p/s/ra-faculty-panel-discussion-and-audience-q-and-a-3018
https://rheumnow.live/lessons/29/index
https://rheumnow.live/lessons/29/index
https://rheumnow.live/lessons/29/index
https://rheumnow.live/lessons/29/index
https://rheumnow.live/p/s/welcome-remarks-3078
https://rheumnow.live/lessons/29/index
https://rheumnow.live/lessons/29/index
https://rheumnow.live/p/s/welcome-remarks-and-keynote-address-3114
https://rheumnow.live/p/s/pre-test-3377
https://rheumnow.live/p/s/overall-evaluation-3383
https://rheumnow.live/lessons/29/index
https://rheumnow.live/lessons/29/index
https://rheumnow.live/lessons/29/index
https://rheumnow.live/lessons/29/index
https://rheumnow.live/lessons/29/index
https://rheumnow.live/p/s/post-event-survey-3475
https://rheumnow.live/p/cf/pre-learning-collection-2022-3482
https://rheumnow.live/p/cf/rheumnow-live-2022-3503
https://rheumnow.live/p/s/breakfast-3505
https://rheumnow.live/p/s/opening-remarks-3510
https://rheumnow.live/p/s/pod-1-rheumatoid-arthritis-future-improvements-3515
https://rheumnow.live/p/s/treatment-choices-in-refractory-ra-3520
https://rheumnow.live/p/s/adherence-to-rheumatoid-therapies-3525
https://rheumnow.live/p/s/precision-medicine-in-rheumatoid-arthritis-3530
https://rheumnow.live/p/s/rheumatoid-faculty-panel-q-and-a-3535
https://rheumnow.live/p/s/the-music-of-rheumatology-3540
https://rheumnow.live/p/s/visit-the-virtual-exhibit-hall-3545
https://rheumnow.live/p/s/pod-2-systemic-lupus-erythematosus-3550
https://rheumnow.live/p/s/lupus-nephritis-the-blind-men-and-the-kidney-3555
https://rheumnow.live/p/s/novel-treatment-of-sle-3560
https://rheumnow.live/p/s/the-almighty-ana-3565
https://rheumnow.live/p/s/lupus-faculty-panel-q-and-a-3570
https://rheumnow.live/p/s/pod-3-psoriatic-arthritis-advances-3575
https://rheumnow.live/p/s/psa-guidelines-the-good-bad-and-ugly-3580
https://rheumnow.live/p/s/drug-targeting-in-psoriatic-arthritis-3585
https://rheumnow.live/p/s/rwe-and-registries-in-psoriatic-arthritis-3590
https://rheumnow.live/p/s/psoriatic-faculty-panel-q-and-a-3595
https://rheumnow.live/p/s/who-killed-caravaggio-3600
https://rheumnow.live/p/s/the-pregnancy-paradox-how-stopping-drugs-to-protect-the-fetus-leads-to-greater-harm-3605
https://rheumnow.live/p/s/visit-the-virtual-exhibit-hall-3610
https://rheumnow.live/p/s/pod-4-spondyloarthritis-spectrum-3615
https://rheumnow.live/p/s/the-microbiome-in-spondyloarthritis-3620
https://rheumnow.live/p/s/axial-psoriatic-arthritis-3625
https://rheumnow.live/p/s/juvenile-spondyloarthritis-3630
https://rheumnow.live/p/s/spondyloarthritis-faculty-panel-q-and-a-3635
https://rheumnow.live/p/s/rheumnow-distilled-reception-3640
https://rheumnow.live/p/s/visit-the-virtual-exhibit-hall-3645
https://rheumnow.live/p/s/pod-5-psoriatic-disease-for-rheumatologists-3650
https://rheumnow.live/p/s/advances-in-psoriasis-management-3655
https://rheumnow.live/p/s/psoriasis-management-cases-3660
https://rheumnow.live/p/s/comanagement-of-psoriasis-and-psoriatic-arthritis-3665
https://rheumnow.live/p/s/pod-6-hot-topics-in-rheumatology-3670
https://rheumnow.live/p/s/rethinking-pain-and-analgesia-3675
https://rheumnow.live/p/s/fatigue-and-central-sensitization-in-rheumatic-disease-3680
https://rheumnow.live/p/s/adults-with-juvenile-idiopathic-arthritis-it-aint-all-childs-play-3685
https://rheumnow.live/p/s/visit-the-virtual-exhibit-hall-3690
https://rheumnow.live/p/s/pod-7-rheumatoid-arthritis-best-management-3695
https://rheumnow.live/p/s/drug-cycling-vs-switching-in-ra-3700
https://rheumnow.live/p/s/multimorbidity-in-ra-what-clinicians-should-know-3705
https://rheumnow.live/p/s/preventing-rheumatoid-arthritis-3710
https://rheumnow.live/p/s/rheumatoid-faculty-panel-q-and-a-3715
https://rheumnow.live/p/s/adjourn-3720
https://rheumnow.live/p/s/treatment-choices-in-refractory-ra-3740
https://rheumnow.live/p/s/adherence-to-rheumatoid-therapies-3745
https://rheumnow.live/p/s/precision-medicine-in-rheumatoid-arthritis-3750
https://rheumnow.live/p/s/lupus-nephritis-the-blind-men-and-the-kidney-3770
https://rheumnow.live/p/s/novel-treatment-of-sle-3775
https://rheumnow.live/p/s/the-almighty-ana-3780
https://rheumnow.live/p/s/psa-guidelines-the-good-bad-and-ugly-3795
https://rheumnow.live/p/s/drug-targeting-in-psoriatic-arthritis-3800
https://rheumnow.live/p/s/rwe-and-registries-in-psoriatic-arthritis-3805
https://rheumnow.live/p/s/the-microbiome-in-spondyloarthritis-3830
https://rheumnow.live/p/s/axial-psoriatic-arthritis-3835
https://rheumnow.live/p/s/juvenile-spondyloarthritis-3840
https://rheumnow.live/p/s/advances-in-psoriasis-management-3860
https://rheumnow.live/p/s/psoriasis-management-cases-3865
https://rheumnow.live/p/s/comanagement-of-psoriasis-and-psoriatic-arthritis-3870
https://rheumnow.live/p/s/rethinking-pain-and-analgesia-3880
https://rheumnow.live/p/s/fatigue-and-central-sensitization-in-rheumatic-disease-3885
https://rheumnow.live/p/s/adults-with-juvenile-idiopathic-arthritis-it-aint-all-childs-play-3890
https://rheumnow.live/p/s/drug-cycling-vs-switching-in-ra-3900
https://rheumnow.live/p/s/multimorbidity-in-ra-what-clinicians-should-know-3905
https://rheumnow.live/p/s/preventing-rheumatoid-arthritis-3910
https://rheumnow.live/p/cf/sponsor-posters-2022-3916
https://rheumnow.live/p/s/disease-severity-and-healthcare-costs-associated-with-chronic-kidney-disease-in-patients-with-systemic-lupus-erythematosus-3921
https://rheumnow.live/p/s/characterizing-patient-and-physician-perceptions-of-systemic-lupus-erythematosus-sle-disease-burden-using-traditional-rheumatoid-arthritis-outcomes-measures-3926
https://rheumnow.live/p/s/virtual-rheumatology-scientific-booth-3931
https://rheumnow.live/p/s/bimekizumab-in-patients-with-psoriatic-arthritis-3-year-results-for-overall-and-tumor-necrosis-factor-inhibitor-tnfi-naive-populations-from-a-phase-2b-open-label-extension-study-3956
https://rheumnow.live/p/s/glaxeffects-of-belimumab-bel-on-renal-outcomes-in-patients-with-relapsed-and-newly-diagnosed-active-lupus-nephritis-ln-3961
https://rheumnow.live/p/s/the-effect-of-treatment-with-the-complement-c5a-receptor-inhibitor-avacopan-on-health-related-quality-of-life-in-anca-associated-vasculitis-4010
https://rheumnow.live/p/s/effect-of-avacopan-a-selective-c5a-receptor-inhibitor-on-kidney-function-in-patients-with-anca-associated-vasculitis-4012
https://rheumnow.live/p/s/glucocorticoid-toxicity-index-and-the-advocate-trial-4015
https://rheumnow.live/p/s/followup-survey-4021
https://rheumnow.live/p/cf/rheumnow-live-2023-4042
https://rheumnow.live/p/s/welcome-and-introductions-4044
https://rheumnow.live/p/s/rheumatoid-arthritis-revolutionary-advances-in-therapy-4045
https://rheumnow.live/p/s/preclinical-ra-to-treat-or-not-to-treat-4046
https://rheumnow.live/p/s/year-of-the-jaki-4047
https://rheumnow.live/p/s/fibroblasts-stromal-cells-that-hold-exciting-promise-for-treating-ra-4048
https://rheumnow.live/p/s/ra-faculty-panel-q-and-a-4049
https://rheumnow.live/p/s/step-insights-into-the-future-of-osteoarthritis-4050
https://rheumnow.live/p/s/modern-management-of-psoriatic-arthritis-4052
https://rheumnow.live/p/s/remission-in-psoriatic-arthritis-4053
https://rheumnow.live/p/s/jak-inhibitors-in-psoriasis-and-psa-4054
https://rheumnow.live/p/s/pregnancy-in-psa-4055
https://rheumnow.live/p/s/psa-faculty-panel-q-and-a-4056
https://rheumnow.live/p/s/vasculitis-evolution-and-advances-4058
https://rheumnow.live/p/s/new-therapies-for-pmr-and-gca-4059
https://rheumnow.live/p/s/assessment-of-gca-and-pmr-4060
https://rheumnow.live/p/s/gpa-treatment-choices-4061
https://rheumnow.live/p/s/vasculitis-faculty-panel-q-and-a-4062
https://rheumnow.live/p/s/step-all-in-the-family-rheum-4063
https://rheumnow.live/p/s/rheumatoid-arthritis-decisive-therapeutics-4065
https://rheumnow.live/p/s/methotrexate-use-50-yr-perspective-4066
https://rheumnow.live/p/s/myths-vs-reality-in-ra-4067
https://rheumnow.live/p/s/biosimilars-back-on-the-agenda-4068
https://rheumnow.live/p/s/ra-faculty-panel-q-and-a-4069
https://rheumnow.live/p/s/adjourn-4070
https://rheumnow.live/p/s/rheumnow-distilled-reception-4071
https://rheumnow.live/p/s/keynote-covid-19-the-miracle-larry-story-and-rheumatologists-input-4072
https://rheumnow.live/p/s/sle-standards-of-care-4073
https://rheumnow.live/p/s/hydroxychloroquine-a-wonder-drug-for-all-sle-patients-4074
https://rheumnow.live/p/s/new-concepts-in-sle-4075
https://rheumnow.live/p/s/approach-to-lupus-nephritis-4076
https://rheumnow.live/p/s/sle-faculty-panel-q-and-a-4077
https://rheumnow.live/p/s/step-meetings-should-be-like-oktoberfest-4080
https://rheumnow.live/p/s/spondyloarthritis-innovations-4082
https://rheumnow.live/p/s/five-advances-in-spondyloarthritis-4083
https://rheumnow.live/p/s/evaluation-of-sacroiliac-joint-4084
https://rheumnow.live/p/s/a-family-history-of-as-4085
https://rheumnow.live/p/s/spondyloarthritis-faculty-panel-q-and-a-4086
https://rheumnow.live/p/s/adjourn-4089
https://rheumnow.live/p/s/integrated-safety-4113
https://rheumnow.live/p/s/glucocorticoid-gc-free-resolution-of-polymyalgia-rheumatica-pmr-signs-and-symptoms-in-patients-treated-with-sarilumab-with-history-of-flare-analysis-from-saphyr-4114
https://rheumnow.live/p/s/sarilumab-in-patients-with-relapsing-polymyalgia-rheumatica-a-phase-3-multicenter-randomized-double-blind-placebo-controlled-trial-saphyr-4115
https://rheumnow.live/p/s/patient-reported-outcomes-from-a-randomized-controlled-phase-3-trial-of-sarilumab-in-polymyalgia-rheumatica-4116
https://rheumnow.live/p/s/bimekizumab-maintains-improvements-in-efficacy-endpoints-and-has-a-consistent-safety-profile-through-52-weeks-in-patients-with-non-radiographic-axial-spondyloarthritis-and-ankylosing-spondylitis-resul-4117
https://rheumnow.live/p/s/rheumatology-year-in-review-4118
https://rheumnow.live/p/s/pre-test-4123
https://rheumnow.live/p/s/post-test-4131
https://rheumnow.live/p/cf/rheumnow-live-2024-posters-4191
https://rheumnow.live/p/s/post-event-survey-4193
https://rheumnow.live/packages/125/view
https://rheumnow.live/p/s/virtual-showcase-clinical-relevance-of-high-rheumatoid-factor-in-patients-with-rheumatoid-arthritis-non-cme-4243
https://rheumnow.live/p/s/virtual-showcase-defy-expectations-challenge-treatment-goals-in-your-adult-tnfi-ir-patients-with-active-psoriatic-arthritis-psa-non-cme-4244
https://rheumnow.live/p/s/breakfast-4247
https://rheumnow.live/p/s/welcome-and-introductions-4248
https://rheumnow.live/p/s/rheumatoid-arthritis-success-in-rheumatoid-arthritis-4249
https://rheumnow.live/p/s/lessons-from-cardio-rheumatology-clinic-4250
https://rheumnow.live/p/s/nutrition-in-ra-4251
https://rheumnow.live/p/s/prevention-of-ra-4252
https://rheumnow.live/p/s/ra-faculty-panel-q-and-a-4253
https://rheumnow.live/p/s/step-immunosenescence-in-ra-4254
https://rheumnow.live/p/s/step-lest-we-forget-the-flare-4255
https://rheumnow.live/p/s/break-visit-the-virtual-exhibit-hall-4256
https://rheumnow.live/p/s/psoriatic-arthritis-hot-topics-4258
https://rheumnow.live/p/s/eular-vs-acr-vs-grappa-guidelines-4259
https://rheumnow.live/p/s/choosing-systemic-therapies-for-psoriatic-disease-4260
https://rheumnow.live/p/s/gender-differences-in-psa-outcomes-and-management-4261
https://rheumnow.live/p/s/psoriatic-faculty-q-and-a-4262
https://rheumnow.live/p/s/lunch-and-visit-the-virtual-exhibit-hall-4263
https://rheumnow.live/p/s/abbvie-4264
https://rheumnow.live/p/s/jak-inhibitors-in-the-paradigm-4265
https://rheumnow.live/p/s/jak-inhibition-in-spondyloarthritis-4266
https://rheumnow.live/p/s/safety-concerns-with-jak-inhibitors-4267
https://rheumnow.live/p/s/expanding-use-of-jak-inhibitors-in-dermatology-4268
https://rheumnow.live/p/s/jak-faculty-q-and-a-4269
https://rheumnow.live/p/s/break-and-visit-the-virtual-exhibit-hall-4270
https://rheumnow.live/p/s/mastering-sle-4271
https://rheumnow.live/p/s/rethinking-pre-clinical-disease-in-lupus-4272
https://rheumnow.live/p/s/biology-and-rx-of-lupus-flares-4273
https://rheumnow.live/p/s/currentfuture-biomarkers-in-sle-4274
https://rheumnow.live/p/s/sle-faculty-panel-q-and-a-4275
https://rheumnow.live/p/s/rheumnow-distilled-reception-4276
https://rheumnow.live/p/s/breakfast-and-exhibits-4277
https://rheumnow.live/p/s/vasculitis-mavens-4278
https://rheumnow.live/p/s/vasculitis-and-pregnancy-4279
https://rheumnow.live/p/s/gpa-managment-in-2024-4280
https://rheumnow.live/p/s/treat-to-target-in-vasculitis-4281
https://rheumnow.live/p/s/vasculitis-faculty-panel-q-and-a-4282
https://rheumnow.live/p/s/step-ethics-in-rheumatology-4283
https://rheumnow.live/p/s/break-and-visit-the-virtual-exhibit-hall-4284
https://rheumnow.live/p/s/spondyloarthritis-spectrum-4285
https://rheumnow.live/p/s/nonradiographic-axial-spondyloarthritis-4286
https://rheumnow.live/p/s/enthesitis-in-spondyloarthritis-4287
https://rheumnow.live/p/s/future-therapy-of-axial-spondyloarthritis-4288
https://rheumnow.live/p/s/spondyloarthritis-faculty-panel-q-and-a-4289
https://rheumnow.live/p/s/bonus-step-4290
https://rheumnow.live/p/s/step-dead-words-eulogy-4291
https://rheumnow.live/p/s/step-myositis-malignancy-risk-and-screening-4292
https://rheumnow.live/p/s/adjourn-4293
https://rheumnow.live/p/s/sustained-remission-from-weeks-16-to-52-and-weeks-24-to-52-in-patients-treated-with-sarilumab-post-hoc-analysis-of-saphyr-trial-in-patients-with-polymyalgia-rheumatica-4294
https://rheumnow.live/p/s/remission-glucocorticoid-toxicity-health-related-quality-of-life-and-safety-outcomes-in-patients-with-renal-involvement-in-the-phase-3-trial-of-avacopan-for-the-treatment-of-anca-associated-vasculitis-4295
https://rheumnow.live/p/s/pfizer-4296
https://rheumnow.live/p/s/step-appreciative-rheumatology-building-on-the-positive-4297
https://rheumnow.live/p/s/step-myths-and-mistakes-on-anca-associated-vasculitis-4298
https://rheumnow.live/p/s/long-term-safety-and-efficacy-of-bimekizumab-in-patients-with-active-ankylosing-spondylitis-5-year-results-from-a-phase-2b-study-and-its-open-label-extension-4300
https://rheumnow.live/p/s/durability-of-response-among-psoriatic-arthritis-psa-patients-using-biologicaltargeted-synthetic-disease-modifying-antirheumatic-drugs-btsdmards-in-the-corevitas-psaspondyloarthritis-registry-4301
https://rheumnow.live/p/s/post-event-survey-4304
https://rheumnow.live/p/cf/rheumnow-2025-4315
https://rheumnow.live/p/s/welcome-and-introductions-4376
https://rheumnow.live/p/s/pod-i-rheumatoid-arthritis-4377
https://rheumnow.live/p/s/interferons-role-in-sle-4382
https://rheumnow.live/p/s/step-new-steroid-rules-for-lupus-4383
https://rheumnow.live/p/s/bimzelx-r-bimekizumab-bkzx-expert-perspectives-on-a-new-treatment-for-psa-nr-axspa-and-as-by-dr-evan-siegel-4386
https://rheumnow.live/p/s/psoriatic-arthritis-pod-ii-4387
https://rheumnow.live/p/s/jak-inhibitors-pod-iii-4393
https://rheumnow.live/p/s/step-morphea-and-linear-scleroderma-4401
https://rheumnow.live/p/s/step-performance-art-and-medicine-4402
https://rheumnow.live/p/s/keynote-lecture-reinventing-oneself-in-medicine-4403
https://rheumnow.live/p/s/pod-7-spondyloarthritis-4408
https://rheumnow.live/p/s/step-flares-of-rheumatoid-arthritis-4413
https://rheumnow.live/p/s/step-environmental-rheumatology-4414
https://rheumnow.live/p/s/pod-v-vasculitis-4417
https://rheumnow.live/p/s/adjourn-4422
https://rheumnow.live/p/s/optimizing-care-for-pmr-advances-and-challenges-in-diagnosis-and-treatment-by-adam-brown-md-rheumatologist-at-cleveland-clinic-4423
https://rheumnow.live/p/s/opening-reception-4425
https://rheumnow.live/p/s/step-oral-surveillance-3-years-later-4426
https://rheumnow.live/p/s/achieving-your-treatment-goals-consider-when-a-treatment-switch-in-ra-may-be-the-right-transition-for-your-patients-by-dr-alvin-f-wells-md-phd-facp-facr-4441
https://rheumnow.live/p/s/bimekizumab-efficacy-and-safety-in-patients-with-psoriatic-arthritis-who-had-skin-and-nail-psoriasis-at-baseline-up-to-2-year-results-from-two-phase-3-studies-4443